Biota sue GSK.
Well that would be one for the books.
We have been talking about how good IV relenza is for years now.
Remember effect measure
- Forums
- ASX - By Stock
- BTA
- evaluation of intravenous zanamivir
evaluation of intravenous zanamivir, page-6
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online